Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

Summary by Financial Post
EMphora™ platform integrates clinical evidence and predictive modelling to help identify promising cancer patient populations and guide the next phase of research VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, and Boston-based Celvion Therapeutics […]

6 Articles

NiagaraFallsReview.caNiagaraFallsReview.ca
+4 Reposted by 4 other sources
Lean Left

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, and Boston-based Celvion Therapeutics (“Celvion”), today announced the completion of the…

·Niagara Falls, Canada
Read Full Article
pressreach.compressreach.com

Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program - PressReach

VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, and Boston-based Celvion Therapeutics (“Celvion”), today announced the completion of the first analysis in their collaboration using Celvion’s EMphora™ artificial intelligence platform to evaluate potential treatment…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 60% of the sources lean Left
60% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Wednesday, October 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Cancer icon

Cancer

Vancouver, British Columbia icon

Vancouver, British Columbia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal